ClinicalTrials.gg
Enrolling by invitationNCT06723834SERVES+Updated Feb 20, 2026

Service Dogs and Prolonged Exposure Therapy for Military-Connected PTSD

An interventional study of Psychiatric Service Dog and Prolonged Exposure Therapy in Stress Disorders, Post-Traumatic, PTSD and Animal-Human Bonding, sponsored by University of Arizona. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-20.

Sponsored by University of Arizona · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
216
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates the impact of Service Dog partnership on the effectiveness of Prolonged Exposure Therapy. We will learn whether Service Dog partnership in combination with Prolonged Exposure Therapy treatment can help Veterans with PTSD.

Read the detailed description

Posttraumatic stress disorder (PTSD) is common among military Service Members and Veterans (hereafter, "Veterans"). Symptoms of flashbacks, nightmares, and panic attacks can have devastating impacts on Veterans and their families. Suicide and suicidality are also closely linked to PTSD, and the rate of death by suicide among Veterans is nearly double that of the civilian population. PTSD is also difficult to treat. Many Veterans either do not seek treatment at all, or if they start treatment, do not finish. Even if treatment is completed, many Veterans still suffer symptoms and even retain their PTSD diagnosis. There is a critical need to find ways to reduce dropout rates, thus improving the effectiveness of existing, gold-standard treatments and promoting positive outcomes for Veterans and their families.

In their search for effective treatments, some Veterans are turning to add-on interventions for PTSD, such as partnership with a Service Dog. Under the Americans with Disabilities Act (ADA), service dogs are defined as dogs trained to perform specific tasks to mitigate a disability. Service dogs for PTSD are trained in tasks including detecting and alerting to signs of distress to interrupt anxiety and panic attacks and retrieving medication. In addition to trained tasks, service dogs live with the Veterans to provide emotional value as a source of comfort and companionship. Under the ADA guidance, Veterans with PTSD have the legal right to be accompanied by their service dog in public places such as grocery stores, workplaces, and schools. In this study, service dogs will be sourced from participating service dog organizations.

Service Dogs for Veterans are not only increasingly in demand, but a growing body of evidence demonstrates that Service Dogs can significantly improve the lives of Veterans with PTSD. Unfortunately, there is currently no research exploring whether adding a Service Dog will impact the effectiveness of evidence-based PTSD treatments, such as Prolonged Exposure Therapy (PE). Prolonged Exposure Therapy is a gold-standard, frontline treatment for PTSD that is highly effective, but has high rates of dropout.

PE teaches individuals with PTSD to gradually approach trauma-related memories, feelings, and situations that they have been avoiding since their trauma. By confronting these challenges, participants can decrease their PTSD symptoms. PE treatment typically last 12 weeks for 75-90 minutes, once per week.

Initial findings suggest that Service Dogs may help Veterans stay in Prolonged Exposure Therapy resulting in better treatment outcomes. However, some mental health professionals worry that Service Dogs may in fact interfere with treatment goals. This novel study is designed to help understand the impact of Service Dog partnership on the effectiveness of Prolonged Exposure Therapy.

02

Conditions studied

  • Stress Disorders, Post-Traumatic
  • PTSD
  • Animal-Human Bonding
  • Combat Stress Disorders
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's planned enrollment of 216 is above the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

University of Arizona is the lead sponsor of 476 studies on the registry; 88 are open to participants now.

Of its 51 completed or terminated interventional studies of FDA-regulated products, 30 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Applied for and approved to receive a psychiatric service dog from a service dog organization participating in the study
  • Diagnosis of PTSD on the CAPS-5-R

Exclusion criteria

Exclusion Criteria:

  • Current service dog
  • Current participation in Prolonged Exposure Therapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
216 participants (estimated)

Study arms

  • Experimental
    PTSD Service Dog + Prolonged Exposure Therapy

    Participants will receive 12 weeks of Prolonged Exposure once per week with the addition of a service dog

    Other: Psychiatric Service Dog · Behavioral: Prolonged Exposure Therapy

  • Active comparator
    Prolonged Exposure Therapy Alone

    Participants will receive 12 weeks of Prolonged Exposure once per week

    Behavioral: Prolonged Exposure Therapy

Interventions

  • OtherPsychiatric Service Dog

    Partnership with a trained service dog for PTSD.

  • BehavioralProlonged Exposure Therapy

    12 weeks of Prolonged Exposure once per week.

06

What researchers measure

Primary outcomes

  1. PTSD Symptom Severity (Self-report)

    PTSD Checklist for DSM-5 (PCL-5) Total Score; range 0-80; higher scores indicate worse outcome.

    Time frame: 3 months after start of PE

Secondary outcomes

  1. PTSD Symptom Severity (Clinician-assessed)

    Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) Total Score; range 0-200; higher scores indicate worse outcome.

    Time frame: 3 months after start of PE

  2. PTSD Diagnosis

    Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) Diagnosis; binary

    Time frame: 3 months after start of PE

  3. Depression

    Patient Health Questionnaire (PHQ-9); range 0-27; higher scores indicate worse outcome.

    Time frame: 3 months after start of PE

  4. Anxiety

    Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form 8a; T-score range 37 to 83; 50 indicates the population mean with a standard deviation of 10; minimally important difference greater than or equal to 3 points; higher scores indicate worse outcome.

    Time frame: 3 months after start of PE

  5. Emotional affect

    Bradburn Scale of Psychological Wellbeing (BSPW); range -5 to 5; higher scores indicate better outcome.

    Time frame: 3 months after start of PE

  6. Satisfaction with life

    Satisfaction with Life Scale (SWLS); range 3-35; higher scores indicate better outcome.

    Time frame: 3 months after start of PE

  7. Mental health

    Veterans RAND 12-Item Health Survey Mental Component Score (VR-12 MCS); range 0-100; higher scores indicate better outcome.

    Time frame: 3 months after start of PE

Other outcomes

  1. Suicide ideation

    Beck Scale for Suicide Ideation (BSS) Optimized 6-item Scale; range 0-12; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  2. Suicide cognition

    Brief Suicide Cognition Scale (B-SCS); range 6-30; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  3. Intrusion (Clinician-assessed)

    Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5) Criterion B Subscale; range 0-50; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  4. Avoidance (Clinician-assessed)

    Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) Criterion C Subscale; range 0-20; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  5. Cognition and mood (Clinician-assessed)

    Clinician-Administered PTSD Scale for DSM-5 (CAPS-5-R) Criterion D Subscale; range 0-70; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  6. Arousal and reactivity (Clinician-assessed)

    Clinician-Administered PTSD Scale for DSM-5 Revised (CAPS-5-R) Criterion E Subscale; range 0-60; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  7. Intrusion (Self-report)

    PTSD Checklist for DSM-5 (PCL-5) Criterion B Subscale; range 0-20; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  8. Avoidance (Self-report)

    PTSD Checklist for DSM-5 (PCL-5) Criterion C Subscale; range 0-8; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  9. Cognition and mood (Self-report)

    PTSD Checklist for DSM-5 (PCL-5) Criterion D Subscale; range 0-28; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  10. Arousal and reactivity (Self-report)

    PTSD Checklist for DSM-5 (PCL-5) Criterion E Subscale; range 0-24; higher score indicates worse outcome.

    Time frame: 3 months after start of PE

  11. PE Initiation

    Binary; whether or not the participant initiated prolonged exposure therapy

    Time frame: 3 months after start of PE

  12. PE Session Completion

    \# of prolonged exposure therapy sessions completed (out of 12)

    Time frame: 3 months after start of PE

  13. PE Treatment Completion

    Binary; whether or not the participant completed prolonged exposure therapy

    Time frame: 3 months after start of PE

  14. PE Compliance

    \# of inter-session homework assignments completed as part of prolonged exposure therapy

    Time frame: 3 months after start of PE

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06723834
Collaborators
United States Department of Defense
Responsible party
Sponsor
First posted
Dec 9, 2024
Start date
Sep 23, 2025
Primary completion
Sep 30, 2030 (estimated)
Completion
Sep 30, 2030 (estimated)
Last update
Feb 20, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion